Bjond has closed $3.25 million in Series A financing. Draper Triangle Ventures led the round, joined by co-investors TriStar Technology Ventures and Hopen Life Science Ventures.
Today Bjond, Inc. announced that it closed $3.25 million in Series A financing. Draper Triangle Ventures led the round, joined by co-investors TriStar Technology Ventures and Hopen Life Science Ventures. Bjond’s flagship software, BjondHealth, uses workflow automation, decision support, and behavioral economics to transform care management and drive behavior change among chronically ill and worried well people. Bjond has attracted a large payer and provider following and will use its Series A funds to accelerate implementing BjondHealth’s latest version.
“We’re very excited about Bjond and believe its impact on wellness will be profound,” said Will Indest, Managing Director, Draper Triangle. “With BjondHealth, healthcare payers and providers can increase productivity in care management while reducing medical costs and improving patients’ lives.”
“Healthcare faces mounting pressure to provide higher quality care at significantly lower cost. BjondHealth enables payers and providers to deliver efficient care and help chronically ill patients stay healthy while extracting value from legacy care management systems,” said David Blauer, Bjond CEO. “Empowering patients to engage in their health improves outcomes and helps control costs; this is priority one for healthcare leaders.”
About Bjond, Inc.
Bjond, Inc., with offices in Boston and Columbus, provides transformative workflow automation, decision support, and behavior change tools. Its flagship application, BjondHealth, fuels a continuous cycle of data-driven care that profoundly improves patients’ lives. For more information, visit www.bjondinc.com.
About Draper Triangle Ventures
Draper Triangle Ventures is a premier source of funding for early stage high-technology companies in the Midwest. As the Midwest-based partner of Draper Fisher Jurvetson, Draper Triangle offers entrepreneurs a host of benefits unrivaled in the industry.
About TriStar Ventures
TriStar Technology Ventures is an early stage venture firm that invests in companies in healthcare innovation: life sciences, medical technologies, healthcare IT and healthcare services. TriStar’s mission is to identify, create and grow early stage, transformative healthcare companies.
About Hopen Life Science Ventures
Hopen Life Science Ventures invests in promising early-to mid-stage life science and healthcare companies. Hopen manages over $65 million between its two funds. The firm is actively making new investments via Hopen Life Science Fund II.
SOURCE Bjond, Inc.